Clinical grading of vernal keratoconjunctivitis

Current Opinion in Allergy and Clinical Immunology

Volumn 7, Issue 5, 2007, Pages 436-441

  Bonini, Stefano ^a   Sacchetti, Marta ^a   Mantelli, Flavio ^a   Lambiase, Alessandro ^a  

^a UNIVERSITY CAMPUS BIO MEDICO   (Italy)

Author keywords

Allergy; Antiallergic treatments; Cyclosporine A; Steroids; Vernal keratoconjunctivitis

Indexed keywords

ANTIHISTAMINIC AGENT; CYCLOSPORIN A; STEROID;

CATARACTOGENESIS; CLINICAL FEATURE; DEMOGRAPHY; DISEASE ACTIVITY; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFICACY; DRUG MEGADOSE; EYE ALLERGY; EYE INFLAMMATION; GLAUCOMA; HUMAN; IMMUNE RESPONSE; MAST CELL; OUTCOME ASSESSMENT; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SIDE EFFECT; SYMPTOM; TREATMENT DURATION; TREATMENT INDICATION; UNSPECIFIED SIDE EFFECT; VERNAL CONJUNCTIVITIS; VISUAL ACUITY; VISUAL IMPAIRMENT;

ANTI-ALLERGIC AGENTS; CONJUNCTIVA; CONJUNCTIVITIS, ALLERGIC; HUMANS; IMMUNOGLOBULIN E; OPHTHALMIC SOLUTIONS;

EID: 34548681401     PISSN: 15284050     EISSN: 14736322     Source Type: Journal    
DOI: 10.1097/ACI.0b013e3282efb726     Document Type: Review

References (33)

1. Bielory L. Allergic and immunologic disorders of the eye. Part II: Ocular allergy. J Allergy Clin Immunol 2000; 106:1019-1032.
2. Bonini S, Bonini S, Lambiase A, et al. Vernal keratoconjunctivitis revisited: a case series of 195 patients with long-term follow-up. Ophthalmology 2000; 107:1157-1163.
3. Leonardi A, Busca F, Motterle L, et al. Case series of 406 vernal keratoconjunctivitis patients: a demographic and epidemiological study. Acta Ophthalmol Scand 2006; 84:406-410. This study evaluated the specific allergic sensitization and epidemiological characteristics based on data collected in 406 cases of vernal keratoconjunctivitis (VKC).
4. Leonardi A. Vernal keratoconjunctivitis: pathogenesis and treatment. Prog Retin Eye Res 2002; 21:319-339.
5. Pucci N, Novembre E, Lombardi E, et al. Atopy and serum eosinophil cationic protein in 110 white children with vernal keratoconjunctivitis: differences between tarsal and limbal forms. Clin Exp Allergy 2003; 33:325-330.
6. Tuft SJ, Dart JK, Kemeny M. Limbal vernal keratoconjunctivitis: clinical characteristics and immunoglobulin E expression compared with palpebral vernal. Eye 1989; 3 (Pt 4):420-427.
7. Bonini S, Coassin M, Aronni S, Lambiase A. Vernal keratoconjunctivitis. Eye 2004; 18:345-351.
8. Iqbal A, Jan S, Babar TF, Khan MD. Corneal complications of vernal catarrh. J Coll Physicians Surg Pak 2003; 13:394-397.
9. Tabbara KF. Ocular complications of vernal keratoconjunctivitis. Can J Ophthalmol 1999; 34:88-92.
10. Tabbara KF, al-Kharashi SA. Efficacy of nedocromil 2% versus fluorometholone 0.1%:a randomised, double masked trial comparing the effects on severe vernal keratoconjunctivitis. Br J Ophthalmol 1999; 83:180-184.
11. Akman A, Irkec M, Orhan M. Effects of lodoxamide, disodium cromoglycate and fluorometholone on tear leukotriene levels in vernal keratoconjunctivitis. Eye 1998; 12 (Pt 2):291-295.
12. Coutu RB. Treatment of vernal keratoconjunctivitis: a retrospective clinical case study. Wallace F. Molinari Ocular Pharmacology Award. Optom Vis Sci 1991; 68:561-564.
13. Dada T, Konkal V, Tandon R, et al. Corneal topographic response to intraocular pressure reduction in patients with vernal keratoconjunctivitis and steroid-induced glaucoma. Eye 2007; 21:158-163.
14. Kosrirukvongs P, Vichyanond P, Wongsawad W. Vernal keratoconjunctivitis in Thailand. Asian Pac J Allergy Immunol 2003; 21:25-30.
15. Verin P, Allewaert R, Joyaux JC, et al., Lodoxamide Study Group. Comparison of lodoxamide 0.1% ophthalmic solution and levocabastine 0.05% ophthalmic suspension in vernal keratoconjunctivitis. Eur J Ophthalmol 2001; 11:120-125.
16. Verin PH, Dicker ID, Mortemousque B. Nedocromil sodium eye drops are more effective than sodium cromoglycate eye drops for the long-termmanagement of vernal keratoconjunctivitis. Clin Exp Allergy 1999; 29:529-536.
17. Lee S, Allard TR. Lodoxamide in vernal keratoconjunctivitis. Ann Pharmacother 1996; 30:535-537.
18. Foster CS. Evaluation of topical cromolyn sodium in the treatment of vernal keratoconjunctivitis. Ophthalmology 1988; 95:194-201.
19. Avunduk AM, Tekelioglu Y, Turk A, Akyol N. Comparison of the effects of ketotifen fumarate 0.025% and olopatadine HCl 0.1% ophthalmic solutions in seasonal allergic conjunctivities: a 30-day, randomized, double-masked, artificial tear substitute-controlled trial. Clin Ther 2005; 27:1392-1402.
20. Abelson MB. A review of olopatadine for the treatment of ocular allergy. Expert Opin Pharmacother 2004; 5:1979-1994.
21. BenEzra D, Matamoros N, Cohen E. Treatment of severe vernal keratoconjunctivitis with cyclosporine A eyedrops. Transplant Proc 1988; 20 (Suppl 2): 644-649.
22. Mendicute J, Aranzasti C, Eder F, et al. Topical cyclosporin A 2% in the treatment of vernal keratoconjunctivitis. Eye 1997; 11:75-78.
23. Secchi AG, Tognon MS, Leonardi A. Topical use of cyclosporine in the treatment of vernal keratoconjunctivitis. Am J Ophthalmol 1990; 110:641-645.
24. Gupta V, Sahu PK. Topical cyclosporin A in the management of vernal keratoconjunctivitis. Eye 2001; 15:39-41.
25. Bleik JH, Tabbara KF. Topical cyclosporine in vernal keratoconjunctivitis. Ophthalmology 1991; 98:1679-1684.
26. Spadavecchia L, Fanelli P, Tesse R, et al. Efficacy of 1.25% and 1% topical cyclosporine in the treatment of severe vernal keratoconjunctivitis in childhood. Pediatr Allergy Immunol 2006; 17:527-532.
27. Pucci N, Novembre E, Cianferoni A, et al. Efficacy and safety of cyclosporine eyedrops in vernal keratoconjunctivitis. Ann Allergy Asthma Immunol 2002; 89:298-303.
28. Kilic A, Gurler B. Topical 2% cyclosporine A in preservative-free artificial tears for the treatment of vernal keratoconjunctivitis. Can J Ophthalmol 2006; 41:693-698.
29. Friedlaender MH. Current concepts in ocular allergy. Ann Allergy 1991; 67:5-13.
30. Bonini S. Atopic keratoconjunctivitis. Allergy 2004; 59 (Suppl 78):71-73.
31. Bonini S, Bonini S. Studies of allergic conjunctivitis. Chibret Int J 1987; 5:12-22.
32. Bonini S, Bonini S. IgE and non-IgE mechanisms in ocular allergy. Ann Allergy 1993; 71:296-299.
33. Bonini S, Bonini S, Schiavone M, et al. Conjunctival hyperresponsiveness to ocular histamine challenge in subjects with vernal conjunctivitis. J Allergy Clin Immunol 1992; 89:103-107.